SCHEMBL6181264

SCHEMBL6181264

O=C(O)c1ccccc1NS(=O)(=O)c1cccc2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
MCL1 Q07820 1/20 0.62
HTT P42858 1/20 0.62
PFKFB3 Q16875 1/20 0.62
KCNA5 P22460 1/20 0.62
TSHR P16473 1/20 0.62
MEN1 O00255 4/20 0.61
KMT2A Q03164 4/20 0.61
SLC16A3 O15427 5/20 0.59
HSD17B10 Q99714 3/20 0.58
HPGD P15428 2/20 0.58
ATM Q13315 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
BRD4 O60885 1/20 0.54
HCRTR1 O43613 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3561833 0.86 SLC16A3 (0.74) ALDH1A1MCL1HTTPFKFB3KCNA5
SCHEMBL3558973 0.85 SLC16A3 (0.69) ALDH1A1MCL1HTTPFKFB3KCNA5
SCHEMBL3985574 0.84 METAP2 (0.60) ALDH1A1MCL1HTTPFKFB3KCNA5
SCHEMBL3553446 0.84 SLC16A3 (0.68) ALDH1A1MCL1HTTPFKFB3KCNA5
SCHEMBL7199120 0.83 MCL1 (0.70) ALDH1A1MCL1HTTPFKFB3TSHR
SCHEMBL3985999 0.81 METAP2 (0.74) ALDH1A1MCL1HTTPFKFB3KCNA5
SCHEMBL25140720 0.81 USP2 (0.65) ALDH1A1MCL1HTTPFKFB3TSHR
SCHEMBL30806203 0.81 USP2 (0.65) ALDH1A1MCL1HTTPFKFB3TSHR
SCHEMBL3979296 0.81 METAP2 (0.68) ALDH1A1MCL1HTTPFKFB3KCNA5
SCHEMBL2251898 0.80 ACLY (0.61) ALDH1A1MCL1HTTPFKFB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549613-A1 SULFONAMIDES HAVING ANTIANGIOGENIC AND ANTICANCER ACTIVITY Abbott Laboratories (US) 2005-07-06 EP disclosed
WO-2004033419-A1 SULFONAMIDES HAVING ANTIANGIOGENIC AND ANTICANCER ACTIVITY ABBOTT LABORATORIES (US) 2004-04-22 WO disclosed